|
US8030343B2
(en)
*
|
2000-06-08 |
2011-10-04 |
Celgene Corporation |
Pharmaceutically active isoindoline derivatives
|
|
US7311905B2
(en)
*
|
2002-02-13 |
2007-12-25 |
Anthrogenesis Corporation |
Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
|
|
KR100915482B1
(ko)
|
2000-12-06 |
2009-09-03 |
하리리 로버트 제이 |
태반 줄기 세포의 회수 방법
|
|
ES2548591T3
(es)
|
2001-02-14 |
2015-10-19 |
Anthrogenesis Corporation |
Placenta post-parto de mamífero, su uso y células madre placentarias de la misma
|
|
US7498171B2
(en)
*
|
2002-04-12 |
2009-03-03 |
Anthrogenesis Corporation |
Modulation of stem and progenitor cell differentiation, assays, and uses thereof
|
|
AU2003228509B2
(en)
|
2002-10-15 |
2008-06-26 |
Celgene Corporation |
Selective cytokine inhibitory drugs for treating myelodysplastic syndrome
|
|
BR0316695A
(pt)
*
|
2002-11-26 |
2005-10-18 |
Anthrogenesis Corp |
Unidade citoterapêutica, kit para tratamento, método de tratamento de uma enfermidade, biblioteca de unidades citoterapêuticas e método de tratamento de um paciente
|
|
US20050143344A1
(en)
*
|
2003-12-30 |
2005-06-30 |
Zeldis Jerome B. |
Methods and compositions using immunomodulatory compounds for the treatment and management of central nervous system disorders or diseases
|
|
NZ550027A
(en)
*
|
2004-03-26 |
2009-03-31 |
Celgene Corp |
Systems and methods for providing a stem cell bank
|
|
US20080213213A1
(en)
*
|
2004-04-14 |
2008-09-04 |
Zeldis Jerome B |
Method For the Treatment of Myelodysplastic Syndromes Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione
|
|
US7244759B2
(en)
*
|
2004-07-28 |
2007-07-17 |
Celgene Corporation |
Isoindoline compounds and methods of making and using the same
|
|
CA2590903A1
(en)
*
|
2004-12-13 |
2006-06-22 |
Celgene Corporation |
Compositions comprising pde4 modulators and their use for the treatment or prevention of airway inflammation
|
|
CA2823088C
(en)
*
|
2005-06-30 |
2015-10-06 |
Celgene Corporation |
Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds
|
|
WO2007005807A2
(en)
*
|
2005-06-30 |
2007-01-11 |
Anthrogenesis Corporation |
Repair of tympanic membrane using placenta derived collagen biofabric
|
|
US20070021762A1
(en)
*
|
2005-07-13 |
2007-01-25 |
Qing Liu |
Ocular plug formed from placenta derived collagen biofabric
|
|
WO2007009062A2
(en)
*
|
2005-07-13 |
2007-01-18 |
Anthrogenesis Corporation |
Treatment of leg ulcers using placenta derived collagen biofabric
|
|
US20070066512A1
(en)
*
|
2005-09-12 |
2007-03-22 |
Dominique Verhelle |
Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels
|
|
US7878970B2
(en)
|
2005-09-28 |
2011-02-01 |
Boston Scientific Scimed, Inc. |
Apparatus and method for suspending a uterus
|
|
MX343814B
(es)
|
2005-10-13 |
2016-11-24 |
Anthrogenesis Corp |
Inmunomodulación usando celulas madre de la placenta.
|
|
JP5203212B2
(ja)
*
|
2005-10-13 |
2013-06-05 |
アントフロゲネシス コーポレーション |
胎盤由来幹細胞からのオリゴデンドロサイトの産生
|
|
JP2009521931A
(ja)
|
2005-12-29 |
2009-06-11 |
アントフロゲネシス コーポレーション |
胎盤幹細胞を収集及び保存するための改善された組成物、及び該組成物の使用方法
|
|
EP1976978A2
(en)
*
|
2005-12-29 |
2008-10-08 |
Anthrogenesis Corporation |
Co-culture of placental stem cells and stem cells from a second source
|
|
EP2471903B1
(en)
|
2005-12-29 |
2018-02-14 |
Anthrogenesis Corporation |
Placental stem cell populations
|
|
US9144483B2
(en)
|
2006-01-13 |
2015-09-29 |
Boston Scientific Scimed, Inc. |
Placing fixation devices
|
|
WO2007109508A1
(en)
|
2006-03-16 |
2007-09-27 |
Boston Scientific Limited |
System and method for treating tissue wall prolapse
|
|
US20080064876A1
(en)
*
|
2006-05-16 |
2008-03-13 |
Muller George W |
Process for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
|
|
TW200806625A
(en)
*
|
2006-05-26 |
2008-02-01 |
Astrazeneca Ab |
Therapeutic compounds
|
|
US7993918B2
(en)
|
2006-08-04 |
2011-08-09 |
Anthrogenesis Corporation |
Tumor suppression using placental stem cells
|
|
US8105634B2
(en)
*
|
2006-08-15 |
2012-01-31 |
Anthrogenesis Corporation |
Umbilical cord biomaterial for medical use
|
|
US20080131522A1
(en)
*
|
2006-10-03 |
2008-06-05 |
Qing Liu |
Use of placental biomaterial for ocular surgery
|
|
WO2008060377A2
(en)
|
2006-10-04 |
2008-05-22 |
Anthrogenesis Corporation |
Placental or umbilical cord tissue compositions
|
|
CN104623642A
(zh)
|
2006-10-06 |
2015-05-20 |
人类起源公司 |
天然(端肽)胎盘胶原组合物
|
|
EP2418271A3
(en)
|
2006-10-23 |
2015-09-30 |
Anthrogenesis Corporation |
Methods and compositions for treatment of bone defects with placental cell populations
|
|
JP2010518812A
(ja)
|
2007-02-12 |
2010-06-03 |
アンスロジェネシス コーポレーション |
接着性胎盤幹細胞由来の肝細胞および軟骨細胞、ならびにｃｄ３４＋、ｃｄ４５−胎盤幹細胞の濃縮細胞集団
|
|
CN101657206B
(zh)
|
2007-02-12 |
2013-07-03 |
人类起源公司 |
利用胎盘干细胞治疗炎性疾病
|
|
US9200253B1
(en)
|
2007-08-06 |
2015-12-01 |
Anthrogenesis Corporation |
Method of producing erythrocytes
|
|
CN101878034B
(zh)
|
2007-09-28 |
2013-11-20 |
细胞基因细胞疗法公司 |
使用人胎盘灌洗液和人来自胎盘的中间体自然杀伤细胞的肿瘤抑制
|
|
US20090155207A1
(en)
*
|
2007-11-29 |
2009-06-18 |
Hariri Robert J |
Use of Immunomodulatory Compounds for the Treatment of Transverse Myelitis, Multiple Sclerosis, and Other Disorders
|
|
WO2009085234A2
(en)
*
|
2007-12-20 |
2009-07-09 |
Signal Pharmaceuticals, Inc. |
Use of micro-rna as a biomarker of immunomodulatory drug activity
|
|
US9078728B2
(en)
|
2007-12-28 |
2015-07-14 |
Boston Scientific Scimed, Inc. |
Devices and methods for delivering female pelvic floor implants
|
|
US8430807B2
(en)
|
2007-12-28 |
2013-04-30 |
Boston Scientific Scimed, Inc. |
Devices and methods for treating pelvic floor dysfunctions
|
|
WO2009105256A2
(en)
*
|
2008-02-20 |
2009-08-27 |
Celgene Corporation |
Method of treating cancer by administering an immunomodulatory compound in combination with a cd40 antibody or cd40 ligand
|
|
KR20240052847A
(ko)
|
2008-08-20 |
2024-04-23 |
셀룰래리티 인코포레이티드 |
개선된 세포 조성물 및 그의 제조 방법
|
|
US8728805B2
(en)
|
2008-08-22 |
2014-05-20 |
Anthrogenesis Corporation |
Methods and compositions for treatment of bone defects with placental cell populations
|
|
NZ592726A
(en)
|
2008-11-19 |
2012-12-21 |
Anthrogenesis Corp |
Amnion derived adherent cells
|
|
BRPI1007500A2
(pt)
|
2009-02-10 |
2016-02-16 |
Celgene Corp |
métodos de uso e composições que compreendem moduladores de pde4 para tratamento, prevenção e gerenciamento de tuberculose
|
|
CA3110964A1
(en)
|
2009-03-25 |
2010-09-30 |
Xiaokui Zhang |
Preventing a symptom of graft-versus-host disease using human placenta-derived intermediate natural killer cells
|
|
US9125716B2
(en)
|
2009-04-17 |
2015-09-08 |
Boston Scientific Scimed, Inc. |
Delivery sleeve for pelvic floor implants
|
|
JP5645816B2
(ja)
|
2009-05-25 |
2014-12-24 |
国立大学法人東京工業大学 |
中枢神経細胞の増殖及び分化に係る中核因子を含む医薬組成物
|
|
ES2568629T3
(es)
*
|
2009-06-18 |
2016-05-03 |
Concert Pharmaceuticals Inc. |
Derivados deuterados de isoindolin-1,3-diona como inhibidores de PDE4 y TNF-alfa
|
|
AU2013263763B2
(en)
*
|
2009-06-18 |
2016-05-19 |
Concert Pharmaceuticals, Inc. |
Deuterated isoindoline-1,3-dione derivatives as PDE4 and TNF-alpha inhibitors
|
|
AR077369A1
(es)
|
2009-07-02 |
2011-08-24 |
Anthrogenesis Corp |
Metodopara producir eritrocitos sin celulas alimentadoras
|
|
CN102639498A
(zh)
*
|
2009-10-09 |
2012-08-15 |
细胞基因公司 |
制备2-(1-苯乙基)异吲哚啉-1-酮化合物的方法
|
|
WO2011084968A1
(en)
|
2010-01-05 |
2011-07-14 |
Celgene Corporation |
A combination of an immunomodulatory compound and an artemisinin or a derivative thereof for treating cancer
|
|
ES2646750T3
(es)
|
2010-01-26 |
2017-12-15 |
Anthrogenesis Corporation |
Tratamiento de cánceres relacionados con hueso utilizando células madre placentarias
|
|
RS59275B1
(sr)
*
|
2010-02-11 |
2019-10-31 |
Celgene Corp |
Derivati arilmetoksi izoindolina i kompozicije koje ih obuhvataju i postupci njihove primene
|
|
LT2556145T
(lt)
|
2010-04-07 |
2016-11-10 |
Anthrogenesis Corporation |
Angiogenezė naudojant placentos kamienines ląsteles
|
|
MX2012011543A
(es)
|
2010-04-08 |
2013-05-06 |
Anthrogenesis Corp |
Tratamiento de sarcoidosis empleando celulas madre placentarias.
|
|
AU2011268450B2
(en)
|
2010-06-15 |
2015-07-16 |
Amgen (Europe) GmbH |
Biomarkers for the treatment of psoriasis
|
|
JP5996533B2
(ja)
|
2010-07-13 |
2016-09-21 |
アントフロゲネシス コーポレーション |
ナチュラルキラー細胞を生成させる方法
|
|
US8911348B2
(en)
|
2010-09-02 |
2014-12-16 |
Boston Scientific Scimed, Inc. |
Pelvic implants and methods of implanting the same
|
|
CN102558022B
(zh)
*
|
2010-12-22 |
2016-06-15 |
康塞特医药品有限公司 |
取代的异吲哚啉-1,3二酮衍生物
|
|
US8969315B2
(en)
|
2010-12-31 |
2015-03-03 |
Anthrogenesis Corporation |
Enhancement of placental stem cell potency using modulatory RNA molecules
|
|
MX347928B
(es)
|
2011-01-10 |
2017-05-19 |
Celgene Corp |
Derivados de fenetilsulfona isoindolina y su uso.
|
|
US9045417B2
(en)
|
2011-01-14 |
2015-06-02 |
Celgene Corporation |
Isotopologues of isoindole derivatives
|
|
JP2014517915A
(ja)
|
2011-04-18 |
2014-07-24 |
セルジーン コーポレイション |
多発性骨髄腫治療のためのバイオマーカー
|
|
WO2012149299A2
(en)
|
2011-04-29 |
2012-11-01 |
Celgene Corporaiton |
Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
|
|
EP2714059B1
(en)
|
2011-06-01 |
2018-10-03 |
Celularity, Inc. |
Treatment of pain using placental stem cells
|
|
US9938269B2
(en)
|
2011-06-30 |
2018-04-10 |
Abbvie Inc. |
Inhibitor compounds of phosphodiesterase type 10A
|
|
US9925221B2
(en)
|
2011-09-09 |
2018-03-27 |
Celularity, Inc. |
Treatment of amyotrophic lateral sclerosis using placental stem cells
|
|
US9168120B2
(en)
|
2011-09-09 |
2015-10-27 |
Boston Scientific Scimed, Inc. |
Medical device and methods of delivering the medical device
|
|
EP3904875B1
(en)
|
2012-06-29 |
2024-11-20 |
Celgene Corporation |
Methods for determining drug efficacy using ikzf3 (aiolos)
|
|
US9587281B2
(en)
|
2012-08-14 |
2017-03-07 |
Celgene Corporation |
Cereblon isoforms and their use as biomarkers for therapeutic treatment
|
|
JP5934658B2
(ja)
*
|
2013-01-29 |
2016-06-15 |
Ｊｘエネルギー株式会社 |
イミド−ウレア化合物及びその製造方法、グリース用増ちょう剤並びにグリース組成物
|
|
US9763983B2
(en)
|
2013-02-05 |
2017-09-19 |
Anthrogenesis Corporation |
Natural killer cells from placenta
|
|
US9814555B2
(en)
|
2013-03-12 |
2017-11-14 |
Boston Scientific Scimed, Inc. |
Medical device for pelvic floor repair and method of delivering the medical device
|
|
CN105358177B
(zh)
|
2013-04-17 |
2018-11-23 |
西格诺药品有限公司 |
包含tor激酶抑制剂和imid化合物的联合疗法用于治疗癌症
|
|
US9962251B2
(en)
|
2013-10-17 |
2018-05-08 |
Boston Scientific Scimed, Inc. |
Devices and methods for delivering implants
|
|
EP3142663A1
(en)
|
2014-05-16 |
2017-03-22 |
Celgene Corporation |
Compositions and methods for the treatment of atherosclerotic cardiovascular diseases with pde4 modulators
|
|
US10092555B2
(en)
|
2014-06-27 |
2018-10-09 |
Celgene Corporation |
Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
|
|
WO2017070291A1
(en)
|
2015-10-21 |
2017-04-27 |
Celgene Corporation |
Pde4 modulators for treating and preventing immune reconstitution inflammatory syndrome (iris)
|
|
WO2017117118A1
(en)
|
2015-12-28 |
2017-07-06 |
Celgene Corporation |
Compositions and methods for inducing conformational changes in cereblon and other e3 ubiquitin ligases
|
|
KR20230156808A
(ko)
|
2016-12-03 |
2023-11-14 |
주노 쎄러퓨티크스 인코퍼레이티드 |
Car-t 세포의 조절 방법
|
|
IL310031A
(en)
|
2017-05-01 |
2024-03-01 |
Juno Therapeutics Inc |
A combination of cellular therapy and an immune modulatory compound
|
|
EP3630132A1
(en)
|
2017-06-02 |
2020-04-08 |
Juno Therapeutics, Inc. |
Articles of manufacture and methods for treatment using adoptive cell therapy
|
|
US20220225597A1
(en)
|
2017-06-29 |
2022-07-21 |
Juno Therapeutics, Inc. |
Mouse model for assessing toxicities associated with immunotherapies
|
|
US20200246393A1
(en)
|
2017-09-28 |
2020-08-06 |
Celularity, Inc. |
Tumor suppression using human placenta-derived intermediate natural killer (pink) cells in combination with an antibody
|
|
WO2019089858A2
(en)
|
2017-11-01 |
2019-05-09 |
Juno Therapeutics, Inc. |
Methods of assessing or monitoring a response to a cell therapy
|
|
CA3080904A1
(en)
|
2017-11-01 |
2019-05-09 |
Juno Therapeutics, Inc. |
Antibodies and chimeric antigen receptors specific for b-cell maturation antigen
|
|
EP3724225A1
(en)
|
2017-12-15 |
2020-10-21 |
Juno Therapeutics, Inc. |
Anti-cct5 binding molecules and methods of use thereof
|
|
US11325907B2
(en)
|
2018-01-29 |
2022-05-10 |
Medshine Discovery Inc. |
Crystal form of 1H-imidazo[4,5-b]pyridine-2(3H)-one compound and preparation process therefor
|
|
CA3092037A1
(en)
|
2018-02-21 |
2019-08-29 |
Celgene Corporation |
Bcma-binding antibodies and uses thereof
|
|
EP3876958A1
(en)
|
2018-11-08 |
2021-09-15 |
Juno Therapeutics, Inc. |
Methods and combinations for treatment and t cell modulation
|
|
EP3880238A1
(en)
|
2018-11-16 |
2021-09-22 |
Juno Therapeutics, Inc. |
Methods of dosing engineered t cells for the treatment of b cell malignancies
|
|
PL3886875T3
(pl)
|
2018-11-30 |
2024-09-09 |
Juno Therapeutics, Inc. |
Metody leczenia z wykorzystaniem adoptywnej terapii komórkowej
|
|
BR112021014833A2
(pt)
|
2019-01-29 |
2021-10-05 |
Juno Therapeutics, Inc. |
Anticorpos e receptores antigênicos quiméricos específicos para receptor órfão 1 de tipo tirosina quinase de receptor (ror1)
|
|
CN113527179B
(zh)
*
|
2020-04-13 |
2023-07-07 |
苏州璞正医药有限公司 |
链烃取代异吲哚啉-1,3-二酮类pde4抑制剂及其药物用途
|
|
CN113956190B
(zh)
*
|
2021-10-29 |
2023-05-02 |
大连理工大学 |
可激活肿瘤细胞焦亡的细胞器靶向光敏剂及其制备方法和应用
|
|
CN119546638A
(zh)
|
2022-06-22 |
2025-02-28 |
朱诺治疗学股份有限公司 |
用于cd19靶向的car t细胞的二线疗法的治疗方法
|
|
WO2024097905A1
(en)
|
2022-11-02 |
2024-05-10 |
Celgene Corporation |
Methods of treatment with t cell therapy and immunomodulatory agent maintenance therapy
|